A groundbreaking randomized trial sheds new light on patient well-being, economics, and the essential role of patient-reported outcomes, measured using the MacNew Heart Disease questionnaire. In a newly published randomized controlled trial by Bosserdt et al. (2025) in European Radiology, researchers investigated the cost-utility of
Recovering from acute coronary syndrome (ACS) can feel overwhelming. Patients often grapple with uncertainties about managing their health and improving their daily lives. Fortunately, targeted education can dramatically enhance their recovery journey—and the MacNew Heart Disease Health-related Quality of Life Questionnaire has been crucial in
The MacNew continues to be the leading patient reported outcome measure for heart disease world wide. The Asian-Pacific focus of MacNew is constantly growing with three additional language versions now available: Kannada (India), Malayalam (India) and Indonesian (Indonesia). Kannada and Malayalam is spoken by over
Professor Stefan Höfer received the 2017 Research Fellow Award by the International Society for Quality-of-Life studies. Professor Höfer’s pioneering research work in the field of health-related quality of life, in particular in heart disease, was recognised at the 15th International Conference of the International Society
Health-related quality of life (HRQL) is an increasingly well-recognized measure of health outcome in cardiology. HRQL was examined as predictor of unplanned rehospitalization for cardiac reasons in patients after coronary revascularization over a period of 3 years. Two independent studies found the MacNew to be
Sri Lanka with a population of over 15 million people is the latest Asian country joining the growing list of Asian MacNew versions. The Sinhalese translation processes followed a rigorous and repeated forward – backward translation strategy assuring language and cultural adaptation. The Sinhalese version
Recently three new articles investigating the psychometric properties of the MacNew health-related quality of life instrument were published in international peer-reviewed journals for the following languages: French, Russian and Italian. The MacNew is the most wide spread patient reported outcome measure in cardiology assessing all three aspects
We are very proud to announce three new MacNew language versions for Asia. The MacNew is now officially available in Tagalog (Philipines), simplified Chinese (Mainland China, Singapore) and Korean (South Korea). All translatation processes followed a rigerous and repeated forward – backward translation strategy assuring
One of the best predictors of survival is self-reported health by the patient. Recent evidence clearly demonstrates, that changes of 0.5 HRQL points assessed by the MacNew Heart Disease Quality of Life instrument predicts survival of cardiac patients. Deterioration of HRQL, in particular shortly after best
We are pleased to announce three new language versions for the MacNew quality of life instrument: Slovakian, Croatian and Serbian (Latin and Cyrillic). All language translations follow a standard protocol (forward-backward translation) to ensure linguistical and cultural valid versions. The MacNew is now available in